Description: Engineering For New Heights in the Treatment of Inflammatory Bowel Disease
ulcerative colitis (143) ibd (139) monoclonal antibodies (59) inflammatory bowel disease (54) mabs (32) crohn’s disease (31) α4β7 (26) tl1a (26) il-23 (26) uc/cd (26)
Delivering Metabolic Harmony. Transforming Life.
Aeglea specializes in rare metabolic disorders, developing novel medicines to bring better balance to the lives of patients and families battling these devastating diseases.
By engineering small changes in human enzymes, we aim to have a big impact on the lives of patients and their families.